Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2018-03-26 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
关于修改《公司章程》部分条款的公告
Governance Information Classification · 95% confidence The document is an announcement regarding amendments to the company's articles of association (公司章程). It details specific changes to the company's bylaws, including shareholder voting rights, nomination procedures for directors and supervisors, and profit distribution methods. There is no financial data, no mention of a report being attached or published, and no indication of a meeting or voting results. The content is about governance rules and company internal regulations. Therefore, the document fits best under Governance Information (CGR). The document length is short (2170 characters), but it is not a report publication announcement or a regulatory filing. Hence, the classification is CGR with high confidence.
2018-03-26 Chinese
独立董事对相关事项发表的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various company matters including the 2017 profit distribution plan, appointment of auditors, accounting policy changes, related party transactions, internal control evaluation, external guarantees, debt-to-equity conversion, entrusted loans, and appointment of senior management. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and discusses detailed financial figures and corporate governance issues. The document is not a full annual report or audit report but rather a formal independent opinion on specific corporate governance and financial matters, including approval of profit distribution and auditor appointment, which are typically part of board or management information disclosures. The document length is 3012 characters, which is relatively short and focused on independent directors' opinions rather than full financial statements or earnings data. Therefore, it fits best under Board/Management Information (MANG) as it relates to board-level opinions and approvals on key company matters.
2018-03-26 Chinese
七届三次监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding various approvals related to the company's 2017 annual report, financial budget, profit distribution plan, appointment of audit firms, internal control evaluation report, and amendments to the company charter. It includes voting results and mentions submission of some items to the 2017 annual shareholders' meeting. The document is short (1525 characters) and primarily reports on meeting decisions and approvals rather than containing the full annual report or detailed financial statements. It is not the annual report itself but an announcement of supervisory board resolutions related to the annual report and other governance matters. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice rather than a full Annual Report (10-K) or Management Report (MDA).
2018-03-26 Chinese
七届六次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the sixth meeting of the seventh board of directors of 中粮生物化学(安徽)股份有限公司. It includes voting results on various company matters such as the 2017 board work report, financial statements, profit distribution plan, appointment of senior management, amendments to company bylaws, and other operational and financial decisions. The document references the 2017 annual report and other related reports but does not contain the full annual report itself. It is a formal board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is 3880 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2018-03-26 Chinese
关于董事会秘书辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's board secretary. It details the resignation date, reasons, and interim arrangements. There is no financial data, no mention of financial results, reports, or regulatory filings beyond this management change. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2018-03-20 Chinese
关于重大资产重组停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a major asset restructuring (重大资产重组停牌进展公告) and the related stock trading suspension (停牌). It details the timeline of the suspension, regulatory filings, board meetings, shareholder meetings, and ongoing negotiations related to the asset restructuring. The document does not contain financial statements or detailed financial data but rather updates on the status and procedural aspects of the restructuring and trading suspension. It is not a full report like an Annual Report or Interim Report, nor is it a call transcript or earnings release. It is also not a simple report publication announcement since it contains substantive updates on the restructuring progress. The content fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including major asset restructurings and related stock suspension announcements.
2018-03-20 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.